Autoimmune Diseases
4 treatments and conditions followed through the public trial records. Not medical advice.How a status is set
Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Belimumab+SOC for antiphospholipid syndrome | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Biospecimen Collection + Nasal Swab + Survey Administration + REMDESIVIR for autoimmune diseases | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Efgartigimod alfa for immunoglobulin g4-related disease | Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| fetal MSCs combined with 4SCAR T cells for autoimmune diseases | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |